TMO
Thermo Fisher Scientific Inc.
Stock
$675.05−4.56 (−0.67%)Close Sep 30, 2026
Balance sheet
| Line | Q2 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and short-term investments | $4.1B | $10.1B | $5.6B | $8.1B | $8.5B | $4.5B | $10.3B | $2.4B | $2.1B | $1.3B | $786M | $452M | $1.4B | $5.8B | $810M | $1.0B | $926M | $1.6B | $1.3B | $625M |
| Inventory | $5.6B | $5.4B | $5.0B | $5.1B | $5.6B | $5.1B | $4.0B | $3.4B | $3.0B | $3.0B | $2.2B | $2.0B | $1.9B | $1.5B | $1.4B | $1.3B | $1.2B | $1.1B | $1.2B | — |
| Current assets | $23.4B | $28.7B | $22.1B | $24.6B | $25.2B | $20.1B | $22.0B | $11.9B | $10.6B | $9.4B | $7.0B | $5.7B | $6.5B | $9.9B | $4.8B | $4.8B | $4.1B | $4.5B | $4.3B | — |
| Goodwill | $54.8B | $49.4B | $45.9B | $44.0B | $41.2B | $41.9B | $26.0B | $25.7B | $25.3B | $25.3B | $21.3B | $18.8B | $18.8B | $12.5B | $12.5B | $12.0B | $9.0B | $9.0B | $8.7B | — |
| Intangible assets | $18.6B | $15.8B | $15.5B | $16.7B | $17.4B | $20.1B | $12.7B | $14.0B | $15.0B | $16.7B | $14.0B | $12.8B | $14.1B | $7.1B | $7.8B | $7.8B | $5.9B | $6.3B | $6.4B | — |
| Total assets | $113.2B | $110.3B | $97.3B | $98.7B | $97.2B | $95.1B | $69.1B | $58.4B | $56.2B | $56.7B | $45.9B | $40.8B | $42.9B | $31.9B | $27.4B | $26.8B | $21.3B | $21.6B | $21.1B | — |
| Current liabilities | $15.1B | $15.2B | $13.3B | $14.0B | $17.0B | $13.4B | $10.3B | $6.2B | $6.1B | $7.0B | $4.9B | $4.1B | $5.3B | $3.1B | $2.1B | $3.1B | $1.7B | $1.6B | $1.5B | — |
| Long-term debt | $39.2B | $35.9B | $29.1B | $31.3B | $28.9B | $32.3B | $19.1B | $17.1B | $17.7B | $18.9B | $15.4B | $11.4B | $12.4B | $9.5B | $7.0B | $5.8B | $2.0B | $2.1B | $2.0B | — |
| Total liabilities | $60.4B | $56.8B | $47.7B | $51.9B | $53.0B | $54.1B | $34.5B | $28.7B | $28.6B | $31.3B | $24.4B | $19.5B | $22.3B | $15.0B | $12.0B | $11.8B | $6.0B | $6.2B | $6.2B | — |
| Shareholders' equity | $52.7B | $53.4B | $49.6B | $46.7B | $44.0B | $40.8B | $34.5B | $29.7B | $27.6B | $25.4B | $21.5B | $21.4B | $20.5B | $16.9B | $15.5B | $15.0B | $15.4B | $15.4B | $14.9B | $14.5B |
| Shares outstanding | 369.7M | 371.5M | 377.3M | 381.3M | 385.4M | 391.2M | 393.8M | 398.8M | 399.0M | 401.8M | 390.4M | 396.3M | 396.8M | 391.8M | 357.6M | 365.9M | 390.6M | 409.5M | — | — |
| Current ratio | 1.55 | 1.89 | 1.66 | 1.75 | 1.48 | 1.50 | 2.13 | 1.92 | 1.73 | 1.34 | 1.44 | 1.38 | 1.22 | 3.16 | 2.31 | 1.55 | 2.42 | 2.76 | 2.82 | — |